Your browser doesn't support javascript.
loading
Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines.
de Boer, Pieter T; van Lier, Alies; de Melker, Hester; van Wijck, Albert J M; Wilschut, Jan C; van Hoek, Albert Jan; Postma, Maarten J.
Afiliación
  • de Boer PT; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands. pieter.de.boer@rivm.nl.
  • van Lier A; Unit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands. pieter.de.boer@rivm.nl.
  • de Melker H; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
  • van Wijck AJM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
  • Wilschut JC; Pain Clinic, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • van Hoek AJ; Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Postma MJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
BMC Med ; 16(1): 228, 2018 12 06.
Article en En | MEDLINE | ID: mdl-30518427
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Atenuadas / Adyuvantes Inmunológicos / Análisis Costo-Beneficio / Vacuna contra el Herpes Zóster / Herpes Zóster Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Atenuadas / Adyuvantes Inmunológicos / Análisis Costo-Beneficio / Vacuna contra el Herpes Zóster / Herpes Zóster Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos